The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects
In the Sixties, the few anti-thrombotic drugs available were administered following several criteria including tradition of the “School”, preference of the doctor in charge, pressure of pharmaceutical companies [...]
Main Authors: | Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2022-03-01
|
Series: | Bleeding, Thrombosis and Vascular Biology |
Subjects: | |
Online Access: | https://btvb.org/btvb/article/view/24 |
Similar Items
-
Comprehensive Guide to Randomized Controlled Trials in Radiology: Everything You Need to Know
by: Shreya Shukla, et al.
Published: (2025-01-01) -
Is the Movement of Evidence-based Practice a Real Threat to Music Therapy?
by: Masako Otera
Published: (2013-06-01) -
How to appraise the effectiveness of treatment
by: Suzanne B Stewart, et al.
Published: (2011-01-01) -
Evidence-Based Urology: How Does a Randomized Clinical Trial Achieve Its Designed Goals?
by: Sakineh Hajebrahimi, et al.
Published: (2011-06-01) -
A Review of History and Challenges of Evidence-Based Pediatric Surgery
by: George Vaos, et al.
Published: (2022-04-01)